Document is current

Any future updates will be listed below

Isosibiricin inhibits microglial activation by targeting the dopamine D1/D2 receptor-dependent NLRP3/caspase-1 inflammasome pathway

Crossref DOI link: https://doi.org/10.1038/s41401-019-0296-7

Published Online: 2019-09-10

Published Print: 2020-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark